Maudsley Prescribing Guidelines in Psychiatry.
Title:
Maudsley Prescribing Guidelines in Psychiatry.
Author:
Kapur, Shitij.
ISBN:
9780470979693
Personal Author:
Edition:
11th ed.
Physical Description:
1 online resource (682 pages)
Contents:
The Maudsley Prescribing Guidelines in Psychiatry -- Contents -- Preface -- Acknowledgements -- Notes on using The Maudsley Prescribing Guidelines -- Notes on inclusion of drugs -- List of abbreviations -- Chapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants -- Interpreting sample results -- Chapter 2 Schizophrenia -- Antipsychotic drugs -- Antipsychotic drugs: equivalent doses -- Antipsychotic drugs: minimum effective doses -- Antipsychotic drugs: licensed maximum doses -- New antipsychotic drugs -- Antipsychotic drugs: general principles of prescribing -- National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia -- Treatment algorithms for schizophrenia -- Antipsychotic drugs: monitoring of metabolic effects -- Switching antipsychotic drugs because of poor tolerability -- Antipsychotic response: to increase the dose, to switch, to add or just wait - what is the right move? -- Speed and onset of antipsychotic drug action -- First-generation antipsychotic drugs: place in therapy -- Antipsychotic drugs: long-acting injections -- Risperidone long-acting injection -- Paliperidone palmitate long-acting injection -- Management of patients on long-term depots: dose reduction -- Combined antipsychotic drugs -- High-dose antipsychotic drugs: prescribing and monitoring -- Negative symptoms in schizophrenia -- Antipsychotic prophylaxis -- Refractory schizophrenia and clozapine -- Clozapine augmentation -- Refractory schizophrenia: alternatives to clozapine -- Clozapine: management of common adverse effects -- Clozapine: uncommon or unusual adverse effects -- Clozapine: serious haematological and cardiovascular adverse effects -- Clozapine, neutropenia and lithium -- Clozapine and chemotherapy -- Clozapine-related hypersalivation.
Guidelines for the initiation of clozapine for patients based in the community -- Omega-3 fatty acids (fish oils) in schizophrenia -- Extrapyramidal side-effects of antipsychotic drug treatment -- Treatment of antipsychotic-induced akathisia -- Treatment of tardive dyskinesia -- Neuroleptic malignant syndrome -- Catatonia -- Cardiovascular effects of antipsychotic drug treatment -- Antipsychotic drugs and hypertension -- Hyperprolactinaemia -- Antipsychotic-induced weight gain -- Treatment of drug-induced weight gain -- Antipsychotic drugs, diabetes and impaired glucose tolerance -- Antipsychotic drugs and dyslipidaemia -- Antipsychotic drugs and sexual dysfunction -- Antipsychotic-associated hyponatraemia -- Antipsychotics and pneumonia -- Relative adverse effects of antipsychotic drugs: a rough guide -- Chapter 3 Bipolar disorder -- Valproate -- Lithium -- Carbamazepine -- Physical monitoring of people with bipolar disorder -- Treatment of acute mania or hypomania -- Antipsychotic drugs in bipolar disorder -- Bipolar depression -- Rapid cycling bipolar disorder -- Prophylaxis in bipolar disorder -- Chapter 4 Depression and anxiety -- Depression -- Antidepressants -- Treatment of resistant depression -- Treatment of psychotic depression -- Electroconvulsive therapy and psychotropic drugs -- Psychostimulants in depression -- Treatment of depression in the elderly -- Treatment of depression in stroke -- Adverse effects of antidepressants -- Selective serotonin reuptake inhibitors and bleeding -- Depression and diabetes -- Cardiac effects of antidepressants -- Antidepressants and sexual dysfunction -- Antidepressants and hyperprolactinaemia -- Antidepressants: swapping and stopping -- St John's wort in the treatment of depression -- Drug interactions with antidepressants -- Alternative routes of administration for antidepressants.
Anxiety spectrum disorders -- Benzodiazepines in the treatment of psychiatric disorders -- Benzodiazepines and disinhibition -- Benzodiazepines: dependence and detoxification -- Insomnia -- Chapter 5 Children and adolescents -- Principles of prescribing practice in childhood and adolescence -- Depression in children and adolescents -- Bipolar illness in children and adolescents -- Psychosis in children and adolescents -- Anxiety in children and adolescents -- Obsessive compulsive disorder in children and adolescents -- Attention deficit hyperactivity disorder -- Autism spectrum disorders -- Tics and Tourette's syndrome -- Melatonin in the treatment of insomnia in children and adolescents -- Rapid tranquillisation in children and adolescents -- Doses of commonly used psychotropic drugs in children and adolescents -- Chapter 6 Substance misuse -- Alcohol dependence -- Opioid misuse and dependence -- Nicotine and smoking cessation -- Stimulant drugs of dependence -- Benzodiazepine misuse -- y-Butaryl-lactone and y-hydroxybutyrate dependence -- Drugs of misuse: a summary -- Interactions between 'street drugs' and prescribed psychotropic drugs -- Chapter 7 Use of psychotropic drugs in special patient groups -- Epilepsy -- Pregnancy -- Breast feeding -- Renal impairment -- Hepatic impairment -- Prescribing in the elderly -- Dementia -- Behavioural and psychological symptoms of dementia -- Parkinson's disease -- Multiple sclerosis -- Eating disorders -- Acutely disturbed or violent behaviour -- Psychotropic medications for adults with learning disabilities -- Borderline personality disorder -- Delirium -- Huntington's disease -- Psychotropic drugs and surgery -- Prescribing psychotropic drugs for patients with HIV infection -- Psychotropic drugs and cytochrome (CYP) function -- Summary of psychiatric side-effects of non-psychotropic drugs.
Chapter 8 Miscellaneous conditions and substances -- Psychotropic drugs in overdose -- Biochemical and haematological effects of psychotropic drugs -- Prescribing drugs outside their licensed indications -- Observations on the placebo effect in mental illness -- Drug interactions with alcohol -- Nicotine -- Smoking and psychotropic drugs -- Caffeine -- Complementary therapies -- Enhancing medication adherence -- Driving and psychotropic medicines -- Covert administration of medicines within food and drink -- Index.
Abstract:
Helps with complex prescribing needs The evidence base for drug treatments in psychiatry ranges from meta-analyses and randomised controlled clinical trials to single case reports, and from NICE guidelines to individual SPCs. Where do you look for information when transferring a patient from one drug to another? Where do you find a clear overview when dealing with a complex patient (e.g, with co-morbid epilepsy or liver disease or HIV infection)? Where can you seek advice on prescribing psychotropics during pregnancy? The Maudsley Prescribing Guidelines in Psychiatry! The leading clinical reference for handling prescribing problems as encountered in daily practice and for formulating prescribing policy. Evidence-based and written by experts This book is the essential guide for anyone responsible for prescribing, dispensing or administering drugs for patients with mental health disorders. All the evidence has been reviewed and summarized succinctly by an expert team of psychiatrists and pharmacists. New content and improved format This new edition makes greater use of tables and boxes to facilitate quick reference and includes new sections on cytochrome-mediated interactions and psychiatric side effects of non-psychotropic drugs. Clinically relevant Chapters address plasma monitoring, schizophrenia, bipolar disorder, depression and anxiety, children and adolescents, substance abuse and special patient groups. Each section has a full reference list. The book covers prescribing drugs outside their licensed indications and their interaction with substances such as alcohol, nicotine and caffeine. Useful for all levels of experience Trainees will gain important information regarding the rational, safe and effective use of medications for patients with mental illness. Experienced clinicians will find excellent guidance
regarding more complex issues that they may not encounter regularly. Why the Maudsley Prescribing Guidelines in Psychiatry? Long recognized as an international trailblazer in mental health care, the Maudsley Hospital earned its reputation for excellence in both in-patient and community care. It is highly regarded for its research, and pioneered the use of clinical neuroscience. You can trust The Maudsley Prescribing Guidelines in Psychiatry to be scientifically sound and clinically effective.
Local Note:
Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2017. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
Genre:
Electronic Access:
Click to View